Medifast Inc. (MED)
NYSE
11.43
-0.0100 (-0.09%)
Closed
Oct 8, 2026
Day's Range
11.3811.53
52 wk Range
9.2214.15
Financial Statements - MED - Medifast Inc.
Revenue
385.78M▼ 36.0%
Net Income
-18.67M▼ 993.0%Net Margin -4.8%
EBITDA
29.00K▼ 99.8%
Free Cash Flow
1.24M▼ 92.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 385.78M | 602.46M | 1.07B | 1.59B | 1.52B | 934.84M |
| Cost of Goods | 110.60M | 157.84M | 296.20M | 458.16M | 398.49M | 237.02M |
| Gross Profit | 275.18M | 444.62M | 775.85M | 1.14B | 1.12B | 697.81M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -14.21M | 2.87M | 126.40M | 184.80M | 216.24M | 134.15M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 3.05M | -3.89M | -95K | -46K | 119K | -140K |
| Pre Tax Income | -5.63M | 3.78M | 128.79M | 184.05M | 216.12M | 134.26M |
| Income Tax | 13.03M | 1.69M | 29.38M | 40.49M | 52.09M | 31.40M |
| Net Income | -18.67M | 2.09M | 99.41M | 143.56M | 164.03M | 102.85M |
| EPS Basic | -1.7 | 0.19 | 9.1 | 12.82 | 14.01 | 8.74 |
| EPS Diluted | -1.7 | 0.19 | 9.1 | 12.73 | 13.89 | 8.68 |
| Basic Shares Outstanding | 10.98M | 10.93M | 10.88M | 11.19M | 11.70M | 11.77M |
| Diluted Shares Outstanding | 10.98M | 10.93M | 10.88M | 11.19M | 11.70M | 11.77M |
| Ebit | -14.21M | 2.87M | 126.40M | 184.76M | 216.24M | 134.15M |
| Ebitda | 29K | 15.58M | 139.50M | 195.74M | 223.05M | 138.47M |
| Net Income Continuous Operations | -18.67M | 2.09M | 99.41M | 143.56M | 164.03M | 102.85M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
